mynth
08/2024100%LBO

medneo UK acquired by CVC

UNITED KINGDOM Health Providers / Outpatient Care / Radiology REV 1m GBP - 100m GBP

Context

CVC DIF agreed on 7 August 2024 to acquire medneo UK from medneo Group, investing through its third core infrastructure fund. Chief executive Andy Spellman continued to lead the business with his management team, while the seller retained its German and Swiss operations. Established in 2018, medneo UK provides magnetic resonance and computed tomography scanning from mobile units stationed on hospital sites, supplying the scanner, the radiographers who operate it and the arrangements surrounding each examination. Its customers are National Health Service trusts and private healthcare providers, and it conducts more than 130,000 examinations a year from a fleet exceeding twenty vehicles alongside a centre in central London where patients pay directly. Mobile provision answers a particular constraint of the British health service, where waiting times for diagnostic imaging have lengthened and a trust requiring additional capacity must otherwise build a department and recruit radiographers, a process measured in years. A unit that arrives on site and operates within days addresses the backlog without capital expenditure, and the contracts through which it is engaged run over extended periods. Radiographers rather than scanners limit how far such a business can grow, since the machines can be bought but the staff qualified to operate them are in short supply across the health service, which is what distinguishes an operator supplying both from one leasing equipment alone. CVC DIF intended to fund further scanners, the fleet being the constraint on the volume of examinations the company can perform. Travers Smith advised CVC DIF, with L.E.K. on commercial, KPMG on financial and tax and Marsh on insurance matters, while Alantra advised medneo Group, with Freeths as legal counsel, BDO on financial and tax and CIL on commercial due diligence.

The acquisition of medneo UK is part of the growth strategy of CVC, which already has several external growth operations under its belt, notably M Group Services in 2024.

medneo UK, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in Healthcare & Pharma market trends

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (GBP)

Year
Rev
EBITDA
EBIT
2024
£1–100M
[members only]
[members only]
2023
£1–100M
[members only]
[members only]

Other operations with CVC

Other operations with CVC
DateAcquirerTargetCountrySector
10/2024KKR / CVCSUPERSTRUCT ENTERTAINMENTUNITED KINGDOMLeisure Facilities
10/2024CVCADAM ECOTECHSPAINHosting / Datacenter
08/2024CVC / FIDELIOODEVOSWEDENProperty Management
06/2024CVCM GROUP SERVICESUNITED KINGDOMMulti-technical Installation
03/2024CVCPARTNER IN PET FOOD (PPF)HUNGARYPetfood
01/2024CVCLA PIADINERIAITALYRestaurants / Chains
12/2023CVCSOGELINKFRANCEConstruction / Real Estate
07/2022CVC / ADIATMF GROUPNETHERLANDSAccounting & Audit
03/2022CVCRGI GROUPITALYFinancial Services / Banking
12/2021CVC / HPS INVESTMENT PARTNERSAUTHENTIC BRANDS GROUPUNITED STATESFashion & Apparel

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
10/2024QUALIUMIMPC (IMAGERIE MEDICALE PARIS CENTRE)FRANCERadiology
10/2024ARDIANVISTA VISIONITALYOphthalmology
08/2024ORLANDO HEALTHBROOKWOOD BAPTIST HEALTH SERVICESUNITED STATESClinics / Hospitals
06/2024INTEGRAL DIAGNOSTICS LIMITEDCAPITOL HEALTH LIMITEDAUSTRALIARadiology
06/2024L-GAM / CAPZA / IDIA CAPITAL INVESTISSEMENTPSV GROUPFRANCERadiology
01/2024ARDIAN / BPIFRANCE / MACSFAPRIUM PHARMACIEFRANCEPharmacy
12/2023ESSLING CAPITALX-RAY PHOCEAFRANCERadiology
12/2023ANDERA PARTNERSGROUPE IMAGERIE CARDINETFRANCERadiology
10/2023EQT PARTNERSVETPARTNERSAUSTRALIAVet Clinics
08/2023BAIN CAPITALESTIA HEALTHAUSTRALIANursing Homes

REFERENCES

Revenue range: REV 1m GBP - 100m GBP

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of medneo UK by CVC are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: medneo uk

FAQ

What transaction does this page cover?

This page covers CVC’s acquisition of 100% of medneo UK, a British company specialised in Outpatient Care, in 2024, structured as a leveraged buyout (LBO).

What sources support the information on this transaction?

The details of this transaction are sourced directly from the official corporate announcement published on the parties’ institutional website, ensuring primary-source verification of the closing and perimeter.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.